Resultados: 369

    WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia

    In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...

    Guideline for clinical management of exposure to lead

    The purpose of the WHO Guideline for clinical management of exposure to lead is to assist physicians in making decisions about the diagnosis and treatment of lead exposure for individual patients and in mass poisoning incidents. The guideline presents evidence-informed recommendations on: the interpret...

    Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance, 6 October 2021

    Diagnostic testing for SARS-CoV-2 is a critical component to the overall prevention and control strategy for COVID-19. Countries should have a national testing strategy in place with clear objectives that can be adapted according to changes in the epidemiological situation, available resources and tools,...

    WHO global air quality guidelines: particulate matter (‎PM2,5 and PM10)‎, ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide

    Clean air is fundamental to health. Compared to 15 years ago, when the previous edition of these guidelines was published, there is now a much stronger body of evidence to show how air pollution affects different aspects of health at even lower concentrations than previously understood. But here’s what...

    Guideline for preventive chemotherapy for the control of Taenia solium Taeniasis

    The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of Taen...

    Recommendations and guidance on hepatitis C virus self-testing

    Despite recent advances in highly effective and affordable hepatitis C virus (HCV) treatment, many people with HCV infection do not know their status. The World Health Organization (WHO) estimates that 58 million people had chronic HCV infection globally in 2019, and only 21% of them were diagnosed. Lack...

    Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

    These guidelines provide guidance on the diagnosis of HIV infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 201...

    Guidelines for the management of symptomatic sexually transmitted infections

    Worldwide, people acquire more than 1 million curable sexually transmitted infections (STIs) every day. Based on prevalence data from 2009 to 2016, in 2019, WHO published estimates of new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis, showing total estimated incident cases of 376.4 million ...

    Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoringand monitoring: March 2021

    The primary audience for this guideline is national HIV programme managers, people living with HIV, health-care providers and policy-makers in low- and middle-income countries. This guideline update will be a useful resource for clinicians and should help to shape the priorities of policy-makers in devel...

    WHO guidelines for malaria

    The consolidated WHO Guidelines for malaria present all of the current WHO recommendations for malaria. These are the product of careful evaluation following standardized methods as part of the WHO normative processes [1]. WHO uses strictly defined processes to assess the quality, consistency and complet...